1 | Neuroimaging of disseminated germ cell neoplasms. (Mathews VP, Broome DR, Smith RR, Bognanno JR, Einhorn LH, Edwards MK) AJNR Am J Neuroradiol 1990;11(2):319-24 5 Citations |
1 | Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations. (Robins HI, Longo WL, Steeves RA, Cohen JD, Schmitt CL, Neville AJ, O'Keefe S, Lagoni R, Riggs C) Int J Radiat Oncol Biol Phys 1990 Apr;18(4):909-20 29 Citations |
1 | Neuroimaging of disseminated germ cell neoplasms. (Mathews VP, Broome DR, Smith RR, Bognanno JR, Einhorn LH, Edwards MK) AJR Am J Roentgenol 1990 Jun;154(6):1299-304 5 Citations |
1 | Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. (Fuhrman GM, Charnsangavej C, Abbruzzese JL, Cleary KR, Martin RG, Fenoglio CJ, Evans DB) Am J Surg 1994 Jan;167(1):104-11; discussion 111-3 232 Citations |
1 | Rapid-fractionation pre-operative chemoradiation for malignant periampullary neoplasms. (Evans OB, Abbruzzese JL, Cleary KR, Lee JE, Buchholz DJ, Rich TA) J R Coll Surg Edinb 1995 Oct;40(5):319-23 18 Citations |
1 | Nonsquamous cell neoplasms of the adult head and neck. (Smith MM) Top Magn Reson Imaging 1999 Oct;10(5):304-24 3 Citations |
1 | Immunophenotypic analysis of peripheral T-cell neoplasms. A multiparameter flow cytometric approach. (Jamal S, Picker LJ, Aquino DB, McKenna RW, Dawson DB, Kroft SH) Am J Clin Pathol 2001 Oct;116(4):512-26 117 Citations |
1 | Comparison of immunophenotypes of small B-cell neoplasms in primary lymph node and concurrent blood or marrow samples. (Xu Y, McKenna RW, Asplund SL, Kroft SH) Am J Clin Pathol 2002 Nov;118(5):758-64 19 Citations |
1 | Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice. (Cheung WC, Kim JS, Linden M, Peng L, Van Ness B, Polakiewicz RD, Janz S) J Clin Invest 2004 Jun;113(12):1763-73 95 Citations |
1 | Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms. (Wright JD, Powell MA, Herzog TJ, Mutch DG, Rader JS, Gao F, Gibb RK) Gynecol Oncol 2004 Aug;94(2):436-41 21 Citations |
1 | Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. (Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC 3rd, Janz S) Cancer Res 2005 Feb 15;65(4):1306-15 99 Citations |
1 | Maxillary osteoplastic flap technique for the treatment of pediatric pterygopalatine fossa neoplasms. (Patel NJ, Ettema SL, Kerschner JE) Int J Pediatr Otorhinolaryngol 2006 Feb;70(2):295-301 4 Citations |
1 | Relationship of ovarian neoplasms and body mass index. (Wright JD, Powell MA, Mutch DG, Rader JS, Gibb RK, Gao F, Herzog TJ) J Reprod Med 2005 Aug;50(8):595-602 9 Citations |
1 | CD5-positive B-cell neoplasms of indeterminate immunophenotype: a clinicopathologic analysis of 26 cases. (Asplund SL, McKenna RW, Doolittle JE, Kroft SH) Appl Immunohistochem Mol Morphol 2005 Dec;13(4):311-7 16 Citations |
1 | Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. (Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2006 Apr;13(4):582-94 126 Citations |
1 | CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms. (Han SS, Peng L, Chung ST, DuBois W, Maeng SH, Shaffer AL, Sporn MB, Janz S) Mol Cancer 2006 Jun 07;5:22 15 Citations |
1 | Intraductal papillary mucinous neoplasms of the pancreas. (Al-Refaie WB, Choi EA, Tseng JF, Tamm EP, Lee JH, Lee JE, Evans DB, Pisters PW) Med Princ Pract 2006;15(4):245-52 14 Citations |
1 | Myc translocations in B cell and plasma cell neoplasms. (Janz S) DNA Repair (Amst) 2006 Sep 08;5(9-10):1213-24 85 Citations |
1 | Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. (Qi CF, Zhou JX, Lee CH, Naghashfar Z, Xiang S, Kovalchuk AL, Fredrickson TN, Hartley JW, Roopenian DC, Davidson WF, Janz S, Morse HC 3rd) Cancer Res 2007 Mar 15;67(6):2439-47 23 Citations |
1 | Bevacizumab therapy in patients with recurrent uterine neoplasms. (Wright JD, Powell MA, Rader JS, Mutch DG, Gibb RK) Anticancer Res 2007;27(5B):3525-8 40 Citations |
2 | Resection for neoplasms of the pancreas (Sarr MG, Yen TWF, Evans DB, Pedrazzoli S, Pasquali C, Sperti C, Nakakura E, Duncan M, Eckhauser F) Atlas of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery 2007:763-798 1 Citation |
1 | Multidetector computerized tomography urography as the primary imaging modality for detecting urinary tract neoplasms in patients with asymptomatic hematuria. (Sudakoff GS, Dunn DP, Guralnick ML, Hellman RS, Eastwood D, See WA) J Urol 2008 Mar;179(3):862-7; discussion 867 84 Citations |
1 | Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. (Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, Lee JH, Evans DB, Fleming JB) J Am Coll Surg 2008 Jul;207(1):106-20 53 Citations |
1 | Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms. (Atallah E, Verstovsek S) Expert Rev Anticancer Ther 2009 May;9(5):663-70 27 Citations |
1 | Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy. (Saleh HA, Feng J, Tabassum F, Al-Zohaili O, Husain M, Giorgadze T) Cytojournal 2009 Sep 18;6:18 36 Citations |
1 | Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes. (Metcalf RA, Zhao S, Anderson MW, Lu ZS, Galperin I, Marinelli RJ, Cherry AM, Lossos IS, Natkunam Y) Mod Pathol 2010 Mar;23(3):420-33 41 Citations |
1 | CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms. (Tyner JW, Bumm TG, Deininger J, Wood L, Aichberger KJ, Loriaux MM, Druker BJ, Burns CJ, Fantino E, Deininger MW) Blood 2010 Jun 24;115(25):5232-40 193 Citations |
1 | Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms. (Zingone A, Cultraro CM, Shin DM, Bean CM, Morse HC 3rd, Janz S, Kuehl WM) Leukemia 2010 Jun;24(6):1171-8 20 Citations |
1 | Diagnostic performance of chromoendoscopy and narrow band imaging for colonic neoplasms: a meta-analysis. (Kobayashi Y, Hayashino Y, Jackson JL, Takagaki N, Hinotsu S, Kawakami K) Colorectal Dis 2012 Jan;14(1):18-28 17 Citations |
1 | STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates. (Patel MR, Stadler ME, Deal AM, Kim HS, Shores CG, Zanation AM) Laryngoscope 2011 May;121(5):983-9 10 Citations |
1 | Neoplasms and Sleep: Impact and Implications (Crabtree VML, Brimeyer C) Principles and Practice of Pediatric Sleep Medicine: Second Edition March 2014:363-367 1 Citation |
1 | Myeloproliferative neoplasms. (Kim J, Haddad RY, Atallah E) Dis Mon 2012 Apr;58(4):177-94 9 Citations |
1 | Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms. (Qi CF, Kim YS, Xiang S, Abdullaev Z, Torrey TA, Janz S, Kovalchuk AL, Sun J, Chen D, Cho WC, Gu W, Morse Iii HC) Int J Mol Sci 2012;13(5):6204-6219 27 Citations |
1 | Secondary Neoplasms in Childhood Cancer Survivors. (Leuthner, L., Anderson, L., & Schmidt, D. ) The Oncology Nurse |
1 | Follicular, apocrine, sebaceous, and eccrine neoplasms and their disease associations (Walton K, Santoro FA, Kohen L) Journal of Drugs in Dermatology October 2012;11(10):1237-1238 |
1 | Resident rounds: Part II: Follicular, apocrine, sebaceous and eccrine neoplasms and their disease associations (Walton, KE, Santoro, FA and Kohen LA. ) Journal of Drugs in Dermatology J Drugs Dermatol. 2012;11(10):1237-38 |
1 | Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasms. (Keyzner A, D'Souza A, Lacy M, Gertz M, Hayman S, Buadi F, Kumar S, Dingli D, Engebretson A, Tong C, Dispenzieri A) Biol Blood Marrow Transplant 2013 Sep;19(9):1395-8 9 Citations |
1 | Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension. (Yan M, Geyer H, Mesa R, Atallah E, Callum J, Bartoszko J, Yee K, Maganti M, Wong F, Gupta V) Clin Lymphoma Myeloma Leuk 2015 Jan;15(1):e1-5 22 Citations |
1 | Sinonasal neoplasms: Update on classification, imaging features, and management (McCollister KB, Hopper BD, Michel MA) Applied Radiology 1 January 2015;44(12):7-15 13 Citations |
1 | Vascular Neoplasms and Neoplastic-Like Proliferations (North PE and Kincannon J) in Dermatology, Bolognia JL, Jorizzo JL, and Rapini RP, eds., Mosby, London, pp1917-1841, 2003. |
1 | Vascular Neoplasms and Neoplastic-Like Proliferations (North PE and Kincannon J) in Dermatology, 2nd Edition, Bolognia JL, Jorizzo JL, and Rapini RP, eds., Mosby, London, 2008. |
1 | Vascular Neoplasms and Neoplastic-Like Proliferations (North PE and Kincannon J) in Dermatology, 3rd Edition, Bolognia JL, Jorizzo JL, and Rapini RP, eds., Mosby, London, 2012. |
1 | Tyrosine 625 plays a key role and cooperates with tyrosine 630 in MPL W515L-induced signaling and myeloproliferative neoplasms (Yu C, Yang Q, Chen Y, Wang D, Levine R, Crispino J, Wen Q, Huang Z) Cell and Bioscience 2016;6(1) 1 Citation |
5 | Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms. (Hanif A, Hari PN, Atallah E, Carlson KS, Pasquini MC, Michaelis LC) Bone Marrow Transplant 2016 Apr;51(4):617-8 17 Citations |
1 | KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic neoplasms in mice. (Rosean TR, Holman CJ, Tompkins VS, Jing X, Krasowski MD, Rose-John S, Janz S) Blood Cancer J 2016 Feb 26;6(2):e398 16 Citations |
2 | Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms. (Li H, Hasserjian RP, Kroft SH, Harrington AM, Wheaton SE, Pildain A, Ewalt MD, Gratzinger D, Hosking P, Olteanu H) Am J Clin Pathol 2016 Apr;145(4):538-51 26 Citations |
1 | Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature. (Christakis I, Busaidy NL, Cote GJ, Williams MD, Hyde SM, Silva Figueroa AM, Kwatampora LJ, Clarke CN, Qiu W, Lee JE, Perrier ND) Int J Surg 2016 Jul;31:10-6 41 Citations |
1 | Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis. (Schwaederle M, Zhao M, Lee JJ, Lazar V, Leyland-Jones B, Schilsky RL, Mendelsohn J, Kurzrock R) JAMA Oncol 2016 Nov 01;2(11):1452-1459 251 Citations |
1 | National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report. (Morton LM, Saber W, Baker KS, Barrett AJ, Bhatia S, Engels EA, Gadalla SM, Kleiner DE, Pavletic S, Burns LJ) Biol Blood Marrow Transplant 2017 Mar;23(3):367-378 50 Citations |
1 | CAL2 Immunohistochemical Staining Accurately Identifies CALR Mutations in Myeloproliferative Neoplasms. (Nomani L, Bodo J, Zhao X, Durkin L, Loghavi S, Hsi ED) Am J Clin Pathol 2016 Oct;146(4):431-8 13 Citations |
1 | ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival. (Alvarez Argote J, Dasanu CA) Curr Med Res Opin 2018 May;34(5):757-763 17 Citations |
1 | Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms. (Perez Botero J, Ho TP, Hogan WJ, Kenderian S, Gangat N, Tefferi A, Abraham RS, Nguyen P, Oliveira JL, He R, Chen D, Viswanatha D, Rodriguez V, Khan SP, Patnaik MM) Br J Haematol 2018 Jul;182(1):141-145 4 Citations |
1 | Squamous neoplasms arising within tattoos: clinical presentation, histopathology and management. (Junqueira AL, Wanat KA, Farah RS) Clin Exp Dermatol 2017 Aug;42(6):601-606 12 Citations |
2 | Flow Cytometry of B-Cell Neoplasms. (Kroft SH, Harrington AM) Clin Lab Med 2017 Dec;37(4):697-723 15 Citations |
1 | Metastatic and hematolymphoid neoplasms involving the breast: 20-year experience at a Tertiary Center. (Muller KE, Zhao L, Jorns JM) Breast J 2018 Jul;24(4):680-682 2 Citations |
4 | Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. (Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA) Neurosurgery 2018 May 01;82(5):595-603 9 Citations |
2 | GEMMs Are a Gem When it Comes to Defining the Role of HIF2α in Mucinous Cystic Neoplasms. (Boyle KA, Dwinell MB) Cell Mol Gastroenterol Hepatol 2018;5(2):165-166 |
1 | Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages. (Silva-Figueroa A, Villalobos P, Williams MD, Bassett RL Jr, Clarke CN, Lee JE, Busaidy NL, Perrier ND) Surgery 2018 Nov;164(5):960-964 15 Citations |
1 | Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging Scenarios. (Gallan AJ, Choy B, Paner GP) Surg Pathol Clin 2018 Dec;11(4):775-795 7 Citations |
1 | Prevention and control of neoplasms associated with HPV in high-risk groups in Mexico City: The Condesa Study. (Lazcano-Ponce E, Salmerón J, González A, Allen-Leigh B, León-Maldonado L, Magis C, Aranda-Flores C, Conde-González C, Portillo-Romero AJ, Yunes-Díaz E, Rivera-Rivera L, Vargas G, Nyitray AG, Giuliano AR) Salud Publica Mex 2018;60(6):703-712 6 Citations |
1 | Factors Associated With Management of Pediatric Ovarian Neoplasms. (Lawrence AE, Gonzalez DO, Fallat ME, Aldrink JH, Hewitt GD, Hertweck SP, Onwuka A, Bence C, Burns RC, Dillon PA, Ehrlich PF, Fraser JD, Grabowski JE, Hirschl RB, Kabre R, Kohler JE, Lal DR, Landman MP, Leys CM, Mak GZ, Sato TT, Scannell M, Sujka JA, Minneci PC, Deans KJ) Pediatrics 2019 Jul;144(1) 22 Citations |
2 | Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative. (Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel SK) Ann Surg Oncol 2020 Jan;27(1):134-146 12 Citations |
1 | Sinonasal Neoplasms (Agarwal M, Policeni B) Seminars in Roentgenology July 2019;54(3):244-257 8 Citations |
1 | Sinonasal Neoplasms. (Agarwal M, Policeni B) Semin Roentgenol 2019 Jul;54(3):244-257 8 Citations |
1 | Understanding the Value of Tumor Markers in Pediatric Ovarian Neoplasms. (Lawrence AE, Fallat ME, Hewitt G, Hertweck P, Onwuka A, Afrazi A, Bence C, Burns RC, Corkum KS, Dillon PA, Ehrlich PF, Fraser JD, Gonzalez DO, Grabowski JE, Kabre R, Lal DR, Landman MP, Leys CM, Mak GZ, Overman RE, Rademacher BL, Raiji MT, Sato TT, Scannell M, Sujka JA, Wright T, Minneci PC, Deans KJ, Aldrink JH, Midwest Pediatric Surgery Consortium) J Pediatr Surg 2020 Jan;55(1):122-125 23 Citations |
1 | Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms. (Silva-Figueroa AM, Bassett R Jr, Christakis I, Moreno P, Clarke CN, Busaidy NL, Grubbs EG, Lee JE, Perrier ND, Williams MD) Endocr Pathol 2019 Dec;30(4):285-296 20 Citations |
1 | Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology Group. (Kopp LM, Womer RB, Schwartz CL, Ebb DH, Franco VI, Hall D, Barkauskas DA, Krailo MD, Grier HE, Meyers PA, Wexler LH, Marina NM, Janeway KA, Gorlick R, Bernstein ML, Lipshultz SE, Children’s Oncology Group) Cardiooncology 2019;5:15 26 Citations |
2 | The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2553-2560 14 Citations |
3 | The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms. (Chicago Consensus Working Group) Cancer 2020 Jun 01;126(11):2525-2533 34 Citations |
2 | The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms. (Chicago Consensus Working Group) Ann Surg Oncol 2020 Jun;27(6):1780-1787 14 Citations |
2 | The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. (Chicago Consensus Working Group) Ann Surg Oncol 2020 Jun;27(6):1753-1760 55 Citations |
1 |
Incorporation of dermoscopy improves inter-observer agreement among dermatopathologists in histologic assessment of melanocytic neoplasms. (Shi K, Compres E, Walton KE, Mohan LS, Zhang B, Panah E, Quan VL, Garfield EM, Khan AU, Kim D, Yazdan P, Robinson JK, Gerami P.) Archives of Dermatological Research Arch Dermatol Res. 2020 Apr 27. doi: 10.1007/s00403-020-02079-w. Online ahead of print. |
1 | Incorporation of dermoscopy improves inter-observer agreement among dermatopathologists in histologic assessment of melanocytic neoplasms. (Shi K, Compres E, Walton KE, Mohan LS, Zhang B, Panah E, Quan VL, Garfield EM, Khan AU, Kim D, Yazdan P, Robinson JK, Gerami P) Arch Dermatol Res 2021 Mar;313(2):101-108 1 Citation |
6 | Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. (Kahn JM, Brazauskas R, Tecca HR, Bo-Subait S, Buchbinder D, Battiwala M, Flowers MED, Savani BN, Phelan R, Broglie L, Abraham AA, Keating AK, Daly A, Wirk B, George B, Alter BP, Ustun C, Freytes CO, Beitinjaneh AM, Duncan C, Copelan E, Hildebrandt GC, Murthy HS, Lazarus HM, Auletta JJ, Myers KC, Williams KM, Page KM, Vrooman LM, Norkin M, Byrne M, Diaz MA, Kamani N, Bhatt NS, Rezvani A, Farhadfar N, Mehta PA, Hematti P, Shaw PJ, Kamble RT, Schears R, Olsson RF, Hayashi RJ, Gale RP, Mayo SJ, Chhabra S, Rotz SJ, Badawy SM, Ganguly S, Pavletic S, Nishihori T, Prestidge T, Agrawal V, Hogan WJ, Inamoto Y, Shaw BE, Satwani P) Blood Adv 2020 May 12;4(9):2084-2094 15 Citations |
1 | The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms (Hoppenot C, Schuitevoerder D, Izquierdo FJ, Plana A, Pothuri B, Yamada SD, Kim J, Lee NK, Abbott DE, Abdel-Misih S, Ahrendt SA, Al-kasspooles M, Amersi F, Arrington AK, Badgwell B, Barone RM, Baumgartner JM, Berri RN, Bijelic L, Blazer DG, Bowne WB, Brown CK, Catenacci DV, Chan CHF, Chapel DB, Cho CS, Choudry MHA, Clarke CN, Cusack JC, Dachman AH, Deneve JL, Dineen SP, Eng OS, Fernandez LJ, Fleshman J, Gamblin TC, Gangi A, Georgakis GV, Gilbert EW, Goodman MD, Grotz TE, Gushchin V, Hanna N, Harmath C, Hayes-Jordan A, Husain AN, Idrees K, Ihemelandu C, Johnston FM, Jiang D, Kane JM, Karakousis G, Kelly KJ, Kennedy TJ, Keutgen XM, Kindler HL, Kluger MD, Lastra RR, Lee B, Mack LA, Maduekwe UN, Mak GZ, Mammen JMV, Mathew MS, Melis M, Melnitchouk N, Merkow RP, Mogal H, Möller MG, Moroney J, Oto A, Pameijer CR, Pappas SG, Polanco PM, Polite BN, Reddy SS, Royal R, Salti G, Sardi A, Senthil M, Setia N, Sherman SK, Sideris L, Skitzki J, Tun S, Veerapong J, Votanopoulos KI, White MG, Winer JH, Xiao SY, Yantiss RK, Ahuja N, Lowy AM, Alexander HR, Esquivel J, Foster JM, Labow DM, Lambert LA, Levine EA, Staley C) Annals of Surgical Oncology 1 June 2020;27(6):1780-1787 14 Citations |
2 | Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication. (Taskin OC, Clarke CN, Erkan M, Tsai S, Evans DB, Adsay V) J Gastrointest Oncol 2020 Jun;11(3):548-558 12 Citations |
1 | Pancreaticoduodenectomy for the treatment of pancreatic neoplasms in children: A Pediatric Surgical Oncology Research Collaborative study. (Vasudevan SA, Ha TN, Zhu H, Heaton TE, LaQuaglia MP, Murphy JT, Barry WE, Goodhue C, Kim ES, Aldrink JH, Polites SF, Leraas HJ, Rice HE, Tracy ET, Lautz TB, Superina RA, Davidoff AM, Langham MR Jr, Murphy AJ, Bütter A, Davidson J, Glick RD, Grijalva J, Gow KW, Ehrlich PF, Newman EA, Lal DR, Malek MM, Le-Nguyen A, Piché N, Rothstein DH, Short SS, Meyers R, Dasgupta R) Pediatr Blood Cancer 2020 Sep;67(9):e28425 15 Citations |
1 | A sixteen-year single-center retrospective chart review of Spitz nevi and spitzoid neoplasms in pediatric patients. (Davies OMT, Majerowski J, Segura A, Kelley SW, Sokumbi O, Humphrey SR) Pediatr Dermatol 2020 Nov;37(6):1073-1082 6 Citations |
1 | ASO Author Reflections: Low-Grade Appendiceal Mucinous Neoplasms: An Appeal for Standardization and Collaborative Care. (Istl AC, Greer JB, Johnston FM) Ann Surg Oncol 2021 Jul;28(7):3838-3839 |
1 | Management of Low-Grade Appendiceal Mucinous Neoplasms (LAMN): An International Survey of Surgeons Performing CRS and HIPEC. (Istl AC, Gage MM, Esquivel J, Ahuja N, Greer JB, Johnston FM) Ann Surg Oncol 2021 Jul;28(7):3831-3837 5 Citations |
1 | Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group. (Giulino-Roth L, Pei Q, Buxton A, Bush R, Wu Y, Wolden SL, Constine LS, Kelly KM, Schwartz CL, Friedman DL) Blood 2021 Mar 18;137(11):1449-1456 14 Citations |
2 | Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis. (Muraki T, Jang KT, Reid MD, Pehlivanoglu B, Memis B, Basturk O, Mittal P, Kooby D, Maithel SK, Sarmiento JM, Christians K, Tsai S, Evans D, Adsay V) Mod Pathol 2022 Jan;35(1):96-105 14 Citations |
1 | The role of radiation therapy in the management of primary thymic epithelial neoplasms (Johnstone C, Simone CB) Journal of Cancer Metastasis and Treatment 2022;8 |
1 | Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study. (Short SS, Kastenberg ZJ, Wei G, Bondoc A, Dasgupta R, Tiao GM, Watters E, Heaton TE, Lotakis D, La Quaglia MP, Murphy AJ, Davidoff AM, Mansfield SA, Langham MR, Lautz TB, Superina RA, Ott KC, Malek MM, Morgan KM, Kim ES, Zamora A, Lascano D, Roach J, Murphy JT, Rothstein DH, Vasudevan SA, Whitlock R, Lal DR, Hallis B, Bütter A, Baertschiger RM, Lapidus-Krol E, Putra J, Tracy ER, Aldrink JH, Apfeld J, Le HD, Park KY, Rich BS, Glick RD, Fialkowski EA, Utria AF, Meyers RL, Riehle KJ) Cancer 2022 Jul 15;128(14):2786-2795 4 Citations |
1 | Pretransplant Splenic Irradiation in Patients With Myeloproliferative Neoplasms. (Ponce SB, Chhabra S, Hari P, Firat S) Adv Radiat Oncol 2022;7(5):100964 5 Citations |
1 | Management of Myeloproliferative Neoplasms in the Molecular Era: From Research to Practice. (Pettit K, Rezazadeh A, Atallah EL, Radich J) Am Soc Clin Oncol Educ Book 2022 Apr;42:1-19 |
1 | ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms. (Sullivan MJ, Palmer EL, Botero JP) Curr Hematol Malig Rep 2022 Oct;17(5):105-112 7 Citations |
1 | Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study (Short SS, Kastenberg ZJ, Wei G, Bondoc A, Dasgupta R, Tiao GM, Watters E, Heaton TE, Lotakis D, La Quaglia MP, Murphy AJ, Davidoff AM, Mansfield SA, Langham MR, Lautz TB, Superina RA, Ott KC, Malek MM, Morgan KM, Kim ES, Zamora A, Lascano D, Roach J, Murphy JT, Rothstein DH, Vasudevan SA, Whitlock R, Lal DR, Hallis B, Bütter A, Baertschiger RM, Lapidus-Krol E, Putra J, Tracy ER, Aldrink JH, Apfeld J, Le HD, Park KY, Rich BS, Glick RD, Fialkowski EA, Utria AF, Meyers RL, Riehle KJ) Cancer 15 July 2022;128(14):2786-2795 4 Citations |
1 | Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms. (Chovanec J, Tunc I, Hughes J, Halstead J, Mateja A, Liu Y, O'Connell MP, Kim J, Park YH, Wang Q, Le Q, Pirooznia M, Trivedi NN, Bai Y, Yin Y, Hsu AP, McElwee J, Lassiter S, Nelson C, Bandoh J, DiMaggio T, Šelb J, Rijavec M, Carter MC, Komarow HD, Sabato V, Steinberg J, Hafer KM, Feuille E, Hourigan CS, Lack J, Khoury P, Maric I, Zanotti R, Bonadonna P, Schwartz LB, Milner JD, Glover SC, Ebo DG, Korošec P, Caughey GH, Brittain EH, Busby B, Metcalfe DD, Lyons JJ) Blood Adv 2023 May 09;7(9):1796-1810 14 Citations |
3 | Eyelid schwannomas with associated neoplasms: A report of 2 cases. (Brown-Joel Z, Esmaili N, Hong S, Young K, Wanat K) JAAD Case Rep 2022 Dec;30:56-58 1 Citation |
1 | Eyelid schwannomas with associated neoplasms: a report of 2 cases (Brown-Joel Z, Esmaili N, Hong S, Young K, Wanat K) JAAD Case Reports |
4 | Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease. (Eapen M, Brazauskas R, Williams DA, Walters MC, St Martin A, Jacobs BL, Antin JH, Bona K, Chaudhury S, Coleman-Cowger VH, DiFronzo NL, Esrick EB, Field JJ, Fitzhugh CD, Kanter J, Kapoor N, Kohn DB, Krishnamurti L, London WB, Pulsipher MA, Talib S, Thompson AA, Waller EK, Wun T, Horowitz MM) J Clin Oncol 2023 Apr 20;41(12):2227-2237 7 Citations |
1 | Germline Testing of Mismatch Repair Genes Is Needed in the Initial Evaluation of Patients With Muir-Torre Syndrome-Associated Cutaneous Sebaceous Neoplasms: A Case Series. (Cohen PR, Kurzrock R) Cureus 2023 Jan;15(1):e33975 |
1 | Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration. (Jain T, Tsai HL, Elmariah H, Vachhani P, Karantanos T, Wall S, Gondek L, Bashey A, Keyzner A, Tamari R, Grunwald M, Abedin S, Nadiminti K, Iqbal M, Gerds A, Viswabandya A, McCurdy S, Malki MA, Varadhan R, Ali H, Gupta V, Jones RJ, Otoukesh S) Res Sq 2023 Mar 21 |
1 | Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration. (Jain T, Tsai HL, Elmariah H, Vachhani P, Karantanos T, Wall SA, Gondek LP, Bashey A, Keyzner A, Tamari R, Grunwald MR, Abedin S, Nadiminti KV, Iqbal M, Gerds AT, Viswabandya A, McCurdy SR, Al Malki MM, Varadhan R, Ali H, Gupta V, Jones RJ, Otoukesh S) Haematologica 2023 Dec 01;108(12):3321-3332 2 Citations |
2 | Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies. (Gorak EJ, Otterstatter M, Al Baghdadi T, Gillis N, Foran JM, Liu JJ, Bejar R, Gore SD, Kroft SH, Harrington A, Saber W, Starczynowski D, Rollison DE, Zhang L, Moscinski L, Wilson S, Thompson J, Borchert C, Sherman S, Hebert D, Walker ME, Padron E, DeZern AE, Sekeres MA) Blood Adv 2023 Oct 24;7(20):6120-6129 1 Citation |
1 | Reducing Unnecessary Oophorectomies for Benign Ovarian Neoplasms in Pediatric Patients. (Minneci PC, Bergus KC, Lutz C, Aldrink J, Bence C, Breech L, Dillon PA, Downard C, Ehrlich PF, Fallat M, Fraser JD, Grabowski J, Helmrath M, Hertweck P, Hewitt G, Hirschl RB, Kabre R, Lal DR, Landman M, Leys C, Mak G, Markel T, Pressey J, Raiji M, Rymeski B, Saito J, Sato TT, St Peter SD, Cooper J, Deans K, Midwest Pediatric Surgery Consortium) JAMA 2023 Oct 03;330(13):1247-1254 |
1 | Diagnostic Performance of Magnetic Resonance Imaging for Pediatric Ovarian Neoplasms: A Multi-Institutional Review. (Bergus KC, Knaus ME, Onwuka AJ, Afrazi A, Breech L, Corkum KS, Dillon PA, Ehrlich PF, Fallat ME, Fraser JD, Gadepalli SK, Grabowski JE, Hertweck SP, Kabre R, Lal DR, Landman MP, Leys CM, Mak GZ, Markel TA, Merchant N, Overman RE, Rademacher BL, Raiji MT, Rymeski B, Sato TT, Wright T, Aldrink JH, Hewitt GD, Minneci PC, Deans KJ, Midwest Pediatric Surgery Consortium) J Pediatr Adolesc Gynecol 2023 Nov 25 |
1 | ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms. (Hallet J, Clarke CN) Ann Surg Oncol 2024 Mar;31(3):1704-1713 |
2 | Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation. (Guru Murthy GS, Zhang T, Bolon YT, Spellman S, Dong J, Auer P, Saber W) Biomark Res 2024 Jan 25;12(1):10 |
1 | ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms (Hallet J, Clarke CN) Annals of Surgical Oncology March 2024;31(3):1704-1713 |
2 | Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation (Guru Murthy GS, Zhang T, Bolon YT, Spellman S, Dong J, Auer P, Saber W) Biomarker Research December 2024;12(1) |